Over the 10 years to 2020–21, for a client’s own alcohol or drug use:
- the proportion of treatment episodes that ended in an expected cessation decreased overall, falling by 5 percentage points to 60% (Table Ov.7)
- decreases in expected cessation were highest for treatment episodes where the principal drug of concern was ecstasy: (down 18 percentage points to 71%), and amphetamines (down 10 percentage points to 52%), whereas volatile solvents increased over this time (by 16 percentage points) (Table Drg.12).
Over the 10 years to 2020–21, for someone else’s alcohol or drug use:
- the proportion of treatment episodes with an expected cessation decreased from 2011–12 (71%) to 2018–19 (55%), down to 51% in 2020–21. Whereas ‘other’ as a reason for ceasing treatment increased from 13% in 2011–12 to 30% in 2020–21 (Table Ov.7).